We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Avidity Biosciences Inc is a biotechnology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product candidate AOC 1001, is designed to tr... Avidity Biosciences Inc is a biotechnology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product candidate AOC 1001, is designed to treat a rare monogenic muscle disease. Show more
Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire SAN DIEGO, June 21, 2024 SAN DIEGO, June 21, 2024 /PRNewswire/ -- Avidity Biosciences, Inc...
Avidity Biosciences Partners with the FSHD Society to Raise Awareness of Facioscapulohumeral Muscular Dystrophy on World FSHD Day PR Newswire SAN DIEGO, June 20, 2024 FSHD Society to host Avidity...
Avidity Biosciences, Inc. Announces Closing of Upsized Public Offering of Common Stock, Including Full Exercise of Underwriters' Option to Purchase Additional Shares PR Newswire SAN DIEGO, June...
Period β | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.56 | 1.47136100893 | 38.06 | 40.84 | 36.91 | 2354333 | 38.65144258 | CS |
4 | 12.86 | 49.9223602484 | 25.76 | 42 | 25.51 | 2081572 | 36.10393412 | CS |
12 | 12.03 | 45.2425723956 | 26.59 | 42 | 21.56 | 1333129 | 31.16808129 | CS |
26 | 29.25 | 312.166488794 | 9.37 | 42 | 8.86 | 1259189 | 23.79928407 | CS |
52 | 27.28 | 240.564373898 | 11.34 | 42 | 4.825 | 1143389 | 16.49913962 | CS |
156 | 9.4 | 32.1697467488 | 29.22 | 42 | 4.825 | 857841 | 16.91497227 | CS |
260 | 12.12 | 45.7358490566 | 26.5 | 42 | 4.825 | 699351 | 17.84584764 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions